Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
550.7 INR | +2.75% | +2.78% | +66.68% |
Apr. 18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
Apr. 17 | Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+66.68% | 573M | |
+34.00% | 704B | |
+27.63% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+15.04% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- SHILPAMED Stock
- News Shilpa Medicare Limited
- Transcript : Shilpa Medicare Limited, Q3 2024 Earnings Call, Feb 12, 2024